Based on these data, it can be concluded that HCP5‐132aa primarily inhibits ferroptosis by regulating the expression of SLC7A11 and G6PD, thereby promoting malignant proliferation and tumor progression in GC. This evidence concerns the gene SLC7A11 and neoplasm.